HK Stock MarketDetailed Quotes

03692 HANSOH PHARMA

Watchlist

18.800
+0.480+2.62%

Not Open Mar 11 16:08 CST

111.59BMarket Cap21.61P/E (TTM)

HANSOH PHARMA Stock Forum

Asdee

Feb 10 00:20

$HANSOH PHARMA (03692.HK)$ buy

Asdee

Feb 10 00:19

$HANSOH PHARMA (03692.HK)$ is Fly to the Moon

Bull X Bear

Oct 3, 2024 02:14

What would you buy in your Hong Kong portfolio?

Banks: $ABC (01288.HK)$ $BANK OF CHINA (03988.HK)$
Securities & Brokerage: $HTSC (06886.HK)$ $CMSC (06099.HK)$
Gaming Software: $NTES-S (09999.HK)$ $XD INC (02400.HK)$ $NETDRAGON (00777.HK)$
Digital Solutions: $TENCENT (00700.HK)$ $TRAVELSKY TECH (00696.HK)$ $CHINASOFT INT'L (00354.HK)$
Online Retailer: $BABA-W (09988.HK)$ $MEITUAN-W (03690.HK)$ $JD-SW (09618.HK)$
Insurer: $PING AN (02318.HK)$ $AIA (01299.HK)$ $CHINA LIFE (02628.HK)$
Telecommunication: $CHINA MOBILE (00941.HK)$ $CHINA TELECOM (00728.HK)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

Trader’s Edge

Sep 25, 2024 06:05

Columns Chinese Market Blitzkrieg: Is it any different this time?

Background
Chinese indices have been ripping higher the past 2 days. To put things in perspective, this is only the 2nd time in 2024 (and since Jan 2023) where we see the onshore indices post a bigger rally than the HSI.
1st Time (February 2024):CSI 300 was up by+10% while the HSI was up by only +7.7%
2nd Time (September 2024):CSI 300 up by+6.3% while the HSI was up by only +4.9%
So... what led to this sudden outperformance?
On 24th Septem...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

Trader’s Edge

Sep 8, 2024 21:56

Columns Stocks we're watching this week - KMB, MET and more

Stocks to Watch
Kimberly-Clark Corporation (KMB US) $Kimberly-Clark (KMB.US)$
Daily Chart -[BULLISH ↗ **]KMB is holding above mid-term ascending trendline support and hasbeen making a series of higher highs and higher lows. As long as price is holding above 142 support, a further push higher towards 155.70 resistance is expected. Technical indicators are advocating for a bullish scenario.
Alternatively: A daily candlestick closingbelow 142 suppor...

Moomoo AI

Mar 4, 2024 16:46

Hansoh Pharmaceutical Group's high P/E ratio may be due to expected earnings recovery. However, with lower than market growth forecast, the high P/E ratio and positive investor sentiment may not be sustainable. Current trading prices may not be reasonable without significant improvement.

Optimistic Investors Push Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Up 28% But Growth Is Lacking

Moomoo AI

Feb 11, 2024 22:53

Hansoh Pharmaceutical Group's strong financials and moderate growth over the past five years, along with its high rate of profit reinvestment, could potentially boost its stock value in the long-term. Analysts anticipate future earnings momentum.

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Spinee

Jan 17, 2024 20:42

EV maker $BYD COMPANY (01211.HK)$ fell 0.9% at $193.6. $XPENG-W (09868.HK)$ lifted 0.6%. Pharmaceuticals $HANSOH PHARMA (03692.HK)$ and $TRAD CHI MED (00570.HK)$ rebounded to open 4.9% and 2.3% higher. Handset component maker $SUNNY OPTICAL (02382.HK)$ and PC maker $LENOVO GROUP (00992.HK)$ sank 1.4% and 1.3%.
As for financials, $HSBC HOLDINGS (00005.HK)$ opened flat at $57.95. $HKEX (00388.HK)$ lost 0.5% at $231.4. $AIA (01299.HK)$ shed 1.6% at $58.65. Chinese prope...

Spinee: 恒指上涨24点；BABA和BIDU涨幅最大

Spinee

Jan 17, 2024 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

Moomoo AI

Jan 7, 2024 19:51

Despite Hansoh Pharmaceutical's high P/E ratio, its minimal earnings growth and slower future growth vs. the market make its valuation questionable. Shareholders and investors may face disappointment as the high P/E isn't justified by the growth outlook.

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Share Price Not Quite Adding Up

No comment yet

03692 HANSOH PHARMA

HANSOH PHARMA Stock Forum

Trending Stocks